[go: up one dir, main page]

CN113200841B - A new process for the synthesis of racemic naproxen based on Heck coupling - Google Patents

A new process for the synthesis of racemic naproxen based on Heck coupling Download PDF

Info

Publication number
CN113200841B
CN113200841B CN202110433122.XA CN202110433122A CN113200841B CN 113200841 B CN113200841 B CN 113200841B CN 202110433122 A CN202110433122 A CN 202110433122A CN 113200841 B CN113200841 B CN 113200841B
Authority
CN
China
Prior art keywords
crotonamide
heck coupling
methoxynaphthyl
racemic naproxen
hypochlorite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110433122.XA
Other languages
Chinese (zh)
Other versions
CN113200841A (en
Inventor
张倩云
周宏伟
任炼军
石磊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiaxing University
Original Assignee
Jiaxing University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiaxing University filed Critical Jiaxing University
Priority to CN202110433122.XA priority Critical patent/CN113200841B/en
Publication of CN113200841A publication Critical patent/CN113200841A/en
Application granted granted Critical
Publication of CN113200841B publication Critical patent/CN113200841B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/06Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/584Recycling of catalysts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

本发明公开了一种基于Heck偶联合成消旋萘普生的新工艺,该工艺包含:(1)将2‑X取代‑6‑甲氧基萘在钯催化剂和碱作用下与巴豆酰胺于非质子性有机溶剂中发生Heck偶联反应,生成3‑(6‑甲氧基萘基‑2‑)‑巴豆酰胺;(2)将3‑(6‑甲氧基萘基‑2‑)‑巴豆酰胺在次氯酸盐的碱性溶液中,发生霍夫曼降级反应,生成2‑(6‑甲氧基萘基‑2‑)‑丙醛,将2‑(6‑甲氧基萘‑2‑)‑丙醛不经分离,直接加入亚氯酸盐,室温氧化得到消旋萘普生。本发明的工艺无需制备高度活泼的格利雅试剂,无需严苛的无水条件,转化率较高,产物纯化容易。The invention discloses a new process for synthesizing racemic naproxen based on Heck coupling. The process comprises: (1) 2-X-substituted-6-methoxynaphthalene and crotonamide under the action of a palladium catalyst and a base Heck coupling reaction occurs in aprotic organic solvent to generate 3-(6-methoxynaphthyl-2-)-crotonamide; (2) 3-(6-methoxynaphthyl-2-)- In the alkaline solution of hypochlorite, crotonamide undergoes Hoffman degradation reaction to generate 2-(6-methoxynaphthyl-2-)-propionaldehyde, and 2-(6-methoxynaphthalene- 2-)-Propionaldehyde is directly added with chlorite without separation, and oxidized at room temperature to obtain racemic naproxen. The process of the invention does not need to prepare a highly active Grignard reagent, does not need severe anhydrous conditions, has a high conversion rate, and is easy to purify the product.

Description

一种基于Heck偶联合成消旋萘普生的新工艺A new process for the synthesis of racemic naproxen based on Heck coupling

技术领域technical field

本发明涉及一种合成消旋萘普生的工艺,具体涉及一种基于Heck偶联合成消旋萘普生的新工艺。The invention relates to a process for synthesizing racemic naproxen, in particular to a new process for synthesizing racemic naproxen based on Heck coupling.

背景技术Background technique

现有萘普生的合成工艺主要基于两种基本原料,一类是2-酰基-6-甲氧基萘(路线I或II),另一类是2-溴代-6-甲氧基萘,主要有四条合成路线,具体如下:The synthesis technique of existing naproxen is mainly based on two basic raw materials, one is 2-acyl-6-methoxynaphthalene (route I or II), and the other is 2-bromo-6-methoxynaphthalene , there are mainly four synthetic routes, as follows:

(I)

Figure BDA0003031138420000011
(I)
Figure BDA0003031138420000011

(II)

Figure BDA0003031138420000012
(II)
Figure BDA0003031138420000012

(III)

Figure BDA0003031138420000013
(III)
Figure BDA0003031138420000013

(IV)

Figure BDA0003031138420000014
(IV)
Figure BDA0003031138420000014

路线I或II基于2-酰基-6-甲氧基萘为原料,有一个比较重要的缺陷是2-酰基-6-甲氧基萘比较难于制备。在2-酰基-6-甲氧基萘合成中,萘甲醚的第一活性位点,是甲氧基的邻位,现有工艺需对该位置进行保护,酰化后再去保护,路线较长,造成2-酰基-6-甲氧基萘成本偏高。另一个重要缺陷是由于以2-酰基-6-甲氧基萘为原料制备萘普生的工艺涉及Dazen重排或酰基邻位卤化后再制备成缩酮再重排、水解,路线冗长,中间产物不容易结晶提纯。Route I or II are based on 2-acyl-6-methoxynaphthalene as raw material, and have a relatively important defect that 2-acyl-6-methoxynaphthalene is relatively difficult to prepare. In the synthesis of 2-acyl-6-methoxynaphthalene, the first active site of naphthoyl methyl ether is the ortho position of the methoxy group. The existing technology needs to protect this position, and then deprotect it after acylation. The route Longer, resulting in high cost of 2-acyl-6-methoxynaphthalene. Another important defect is that because the process for preparing naproxen with 2-acyl-6-methoxynaphthalene as raw material involves Dazen rearrangement or acyl ortho-halogenation, it is prepared into a ketal and then rearranged, hydrolyzed, and the route is lengthy and intermediate. The product is not easily purified by crystallization.

路线III或IV基于2-溴代-6-甲氧基萘为原料,通过格利雅反应或偶联反应制备萘普生。路线III虽然收率较高,但是涉及到无水无氧的格利雅试剂的制备,工业上水汽的侵入容易造成生产质量不稳定,而且扩大化生产时,用到高度活泼的金属镁,对于安全生产不利。路线IV这一类偶联具有路线短,原料便宜的优点。但是,这类偶联的重要缺陷是转化率较低,影响收率的同时,未转化的原料2-溴代-6-甲氧基萘会干扰产物的纯化。Route III or IV is based on 2-bromo-6-methoxynaphthalene as starting material, and naproxen is prepared by Grignard reaction or coupling reaction. Although the yield of route III is relatively high, it involves the preparation of anhydrous and oxygen-free Grignard reagents, and the intrusion of water vapor in the industry is likely to cause unstable production quality, and when expanding production, highly active metal magnesium is used, which is safe for safety. Bad production. This type of coupling of route IV has the advantages of short route and cheap raw materials. However, the important defect of this type of coupling is that the conversion rate is low, and while the yield is affected, the unconverted raw material 2-bromo-6-methoxynaphthalene will interfere with the purification of the product.

发明内容SUMMARY OF THE INVENTION

本发明的目的是提供一种基于Heck偶联合成消旋萘普生的新工艺,该工艺无需制备高度活泼的格利雅试剂,无需严苛的无水条件,转化率较高,产物纯化容易。The purpose of the present invention is to provide a new process for synthesizing racemic naproxen based on Heck coupling, which does not require the preparation of highly active Grignard reagents, does not require severe anhydrous conditions, has a high conversion rate, and is easy to purify the product.

为了达到上述目的,本发明提供了一种基于Heck偶联合成消旋萘普生的新工艺,该工艺的合成路线为:In order to achieve the above object, the invention provides a kind of new technology based on Heck coupling synthesis racemic naproxen, the synthetic route of this technology is:

Figure BDA0003031138420000021
Figure BDA0003031138420000021

(1)将2-X取代-6-甲氧基萘在钯催化剂和碱作用下与巴豆酰胺于非质子性有机溶剂中发生Heck偶联反应,生成3-(6-甲氧基萘基-2-)-巴豆酰胺;(1) 2-X substituted-6-methoxynaphthalene is subjected to Heck coupling reaction with crotonamide in an aprotic organic solvent under the action of a palladium catalyst and a base to generate 3-(6-methoxynaphthyl- 2-)-crotonamide;

(2)将3-(6-甲氧基萘基-2-)-巴豆酰胺在次氯酸盐的碱性溶液中,发生霍夫曼降级反应,生成2-(6-甲氧基萘基-2-)-丙醛,将2-(6-甲氧基萘-2-)-丙醛不经分离,直接加入亚氯酸盐,室温氧化得到消旋萘普生。(2) 3-(6-methoxynaphthyl-2-)-crotonamide is subjected to Hoffmann degradation reaction in an alkaline solution of hypochlorite to generate 2-(6-methoxynaphthyl -2-)-Propionaldehyde, 2-(6-methoxynaphthalene-2-)-propionaldehyde is directly added to chlorite without separation, and oxidized at room temperature to obtain racemic naproxen.

其中,所述2-X取代-6-甲氧基萘的结构中,X选自卤素或类卤素,所述类卤素选自

Figure BDA0003031138420000022
所述非质子性有机溶剂选自N,N-二甲基甲酰胺、二甲亚砜、N,N-二甲基乙酰胺、乙腈、二氧六环、甲苯、苯、二甲苯和四氢呋喃中任意一种或两种以上;所述巴豆酰胺的结构中,双键的构型为Z型或E型,或巴豆酰胺为二种构型的混合物;所述钯催化剂为PdLnYm,L选自芳基膦配体,n为0到4之间的整数;Y选自卤素负离子或羧酸根,m为0到4之间的整数;所述Heck偶联反应中的碱选自三乙胺、二乙胺、碳酸钾、碳酸钠、碳酸氢钾、碳酸氢钠、磷酸钾、磷酸钠、乙酸钾和乙酸钠中任意一种或两种以上;所述霍夫曼降级反应中的碱选自氢氧化钾和/或氢氧化钠。Wherein, in the structure of the 2-X substituted-6-methoxynaphthalene, X is selected from halogen or halogen-like, and the halogen-like is selected from
Figure BDA0003031138420000022
The aprotic organic solvent is selected from N,N-dimethylformamide, dimethylsulfoxide, N,N-dimethylacetamide, acetonitrile, dioxane, toluene, benzene, xylene and tetrahydrofuran Any one or more than two; in the structure of the crotonamide, the configuration of the double bond is a Z type or an E type, or the crotonamide is a mixture of two configurations; the palladium catalyst is PdLnYm , L is selected from aryl phosphine ligands, n is an integer between 0 and 4; Y is selected from halogen anion or carboxylate, m is an integer between 0 and 4; the base in the Heck coupling reaction is selected from triethyl Any one or more of amine, diethylamine, potassium carbonate, sodium carbonate, potassium bicarbonate, sodium bicarbonate, potassium phosphate, sodium phosphate, potassium acetate and sodium acetate; the alkali in the Hoffmann degradation reaction Selected from potassium hydroxide and/or sodium hydroxide.

优选地,所述Heck偶联反应,为:将2-溴代-6-甲氧基萘、PdYm、配体L、巴豆酰胺和碱溶于非质子性有机溶剂中,氮气吹洗后密闭加热到130℃,搅拌下反应,以获得3-(6-甲氧基萘基-2-)-巴豆酰胺。Preferably, the Heck coupling reaction is as follows: dissolving 2-bromo-6-methoxynaphthalene, PdYm , ligand L, crotonamide and alkali in an aprotic organic solvent, and sealing after nitrogen purging It was heated to 130°C and reacted with stirring to obtain 3-(6-methoxynaphthyl-2-)-crotonamide.

优选地,所述2-溴代-6-甲氧基萘、PdYm、配体L、巴豆酰胺和碱的摩尔比为1:0.005:0.01:1.5:2。Preferably, the molar ratio of 2-bromo-6-methoxynaphthalene, PdY m , ligand L, crotonamide and base is 1:0.005:0.01:1.5:2.

优选地,所述碱为三乙胺;所述配体L为三(2-甲基苯基)-膦;所述PdYm为PdCl2Preferably, the base is triethylamine; the ligand L is tris(2-methylphenyl)-phosphine; and the PdY m is PdCl 2 .

优选地,所述Heck偶联反应结束后,滤去不溶物,滤液浓缩,用热水提取浓缩物,弃去水相,残留物用含水的乙醇、甲醇或异丙醇重结晶,得到3-(6-甲氧基萘基-2-)巴豆酰胺。Preferably, after the Heck coupling reaction is completed, the insolubles are filtered off, the filtrate is concentrated, the concentrate is extracted with hot water, the aqueous phase is discarded, and the residue is recrystallized with water-containing ethanol, methanol or isopropanol to obtain 3- (6-Methoxynaphthyl-2-)crotonamide.

优选地,所述Heck偶联反应结束后,采用硅藻土滤去不溶物。Preferably, after the Heck coupling reaction is completed, diatomaceous earth is used to filter out insoluble matter.

优选地,所述霍夫曼降级反应,为:在含有次氯酸盐和氢氧化物的极性溶剂中,滴入含有3-(6-甲氧基萘基-2-)巴豆酰胺的非质子性有机溶剂,保持反应温度不超过10℃,待反应结束后,去除反应液中的次氯酸盐,然后调节pH值至中性,加热回流,以获得2-(6-甲氧基萘基-2-)-丙醛;其中,所述极性溶剂选自水或甲醇水溶液。Preferably, the Hoffmann degradation reaction is as follows: in a polar solvent containing hypochlorite and hydroxide, dropwise adding a non-ferrous compound containing 3-(6-methoxynaphthyl-2-)crotonamide. Protic organic solvent, keep the reaction temperature not more than 10 ℃, after the reaction is over, remove the hypochlorite in the reaction solution, then adjust the pH value to neutral, and heat under reflux to obtain 2-(6-methoxynaphthalene wherein, the polar solvent is selected from water or methanol aqueous solution.

优选地,所述次氯酸盐、氢氧化物和3-(6-甲氧基萘基-2-)巴豆酰胺的摩尔比为1.2:2.4:1;所述次氯酸盐为次氯酸钠或次氯酸钾,所述氢氧化物为氢氧化钠或氢氧化钾。Preferably, the molar ratio of the hypochlorite, hydroxide and 3-(6-methoxynaphthyl-2-)crotonamide is 1.2:2.4:1; the hypochlorite is sodium hypochlorite or hypochlorite Potassium chlorate, the hydroxide is sodium hydroxide or potassium hydroxide.

优选地,所述次氯酸盐、亚氯酸盐采用亚硫酸盐水溶液去除。Preferably, the hypochlorite and chlorite are removed by using an aqueous solution of sulfite.

优选地,将所述2-(6-甲氧基萘-2-)-丙醛与亚氯酸盐反应结束后,调节溶液至pH小于3,冷却,过滤,滤饼水洗,滤液采用二氯甲烷或二氯乙烷萃取后浓缩,浓缩物与滤饼合并,采用含水的乙醇、甲醇或异丙醇重结晶,得到消旋萘普生。Preferably, after the reaction of the 2-(6-methoxynaphthalene-2-)-propionaldehyde and chlorite is completed, the pH of the solution is adjusted to be less than 3, cooled, filtered, and the filter cake is washed with water, and the filtrate adopts dichloride. After extraction with methane or dichloroethane, the mixture is concentrated, the concentrate is combined with the filter cake, and recrystallized with aqueous ethanol, methanol or isopropanol to obtain racemic naproxen.

本发明的基于Heck偶联合成消旋萘普生的新工艺,具有以下优点:The novel process of synthesizing racemic naproxen based on Heck coupling of the present invention has the following advantages:

本发明的工艺采用2-卤代-6-甲氧基萘作为原料,而不是2-酰基-6-甲氧基萘,原料成本上具有优势,而且与采用2-卤代-6-甲氧基萘的方法相比,本发明的方法无需制备高度活泼的格利雅试剂,无需严苛的无水条件,转化率较高,产物纯化容易。此外,本发明的工艺使用金属催化剂的量较少,成本低、对环境压力小。本发明的工艺中偶联反应的溶剂与催化剂的选取,确保本发明的工艺的反应收率高,霍夫曼降级反应的温度控制与溶剂选取,对反应物转化具有关键的作用。The process of the present invention uses 2-halogenated-6-methoxynaphthalene as a raw material instead of 2-acyl-6-methoxynaphthalene, which has advantages in raw material cost, and is different from the use of 2-halogenated-6-methoxynaphthalene. Compared with the method based on naphthalene, the method of the present invention does not need to prepare a highly active Grignard reagent, does not need severe anhydrous conditions, has a higher conversion rate, and is easy to purify the product. In addition, the process of the present invention uses a small amount of metal catalyst, and has low cost and low environmental pressure. The selection of the solvent and catalyst for the coupling reaction in the process of the present invention ensures that the reaction yield of the process of the present invention is high, and the temperature control and solvent selection of the Hoffman degradation reaction play a key role in the conversion of reactants.

附图说明Description of drawings

图1为本发明3-(6-甲氧基萘基-2-)巴豆酰胺的核磁氢谱图。Fig. 1 is the hydrogen nuclear magnetic spectrum of 3-(6-methoxynaphthyl-2-)crotonamide of the present invention.

图2为本发明3-(6-甲氧基萘基-2-)巴豆酰胺的核磁碳谱图。Fig. 2 is the carbon nuclear magnetic spectrum of 3-(6-methoxynaphthyl-2-)crotonamide of the present invention.

图3为本发明消旋萘普生的核磁氢谱图。Fig. 3 is the hydrogen nuclear magnetic spectrum of racemic naproxen of the present invention.

图4为本发明消旋萘普生的核磁碳谱图。Fig. 4 is the carbon nuclear magnetic spectrum of racemic naproxen of the present invention.

具体实施方式Detailed ways

下面将对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solutions in the embodiments of the present invention will be described clearly and completely below. Obviously, the described embodiments are only a part of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts shall fall within the protection scope of the present invention.

实施例1Example 1

一种基于Heck偶联合成消旋萘普生的新工艺,该工艺的具体步骤如下:A new technology based on Heck coupling synthesis racemic naproxen, the concrete steps of this technology are as follows:

(1)中间体3-(6-甲氧基萘基-2-)巴豆酰胺的合成(1) Synthesis of intermediate 3-(6-methoxynaphthyl-2-)crotonamide

Figure BDA0003031138420000041
Figure BDA0003031138420000041

将24克(0.1mol)2-溴代-6-甲氧基萘、88毫克(0.5mmol)氯化钯、304毫克(1mmol)三(2-甲基苯基)-膦、13克(0.15mol)巴豆酰胺和20克(0.2mol)三乙胺溶于100mL二甲基甲酰胺中,氮气吹洗三遍后密闭加热到130℃,持续搅拌20h。24 g (0.1 mol) 2-bromo-6-methoxynaphthalene, 88 mg (0.5 mmol) palladium chloride, 304 mg (1 mmol) tris(2-methylphenyl)-phosphine, 13 g (0.15 mol) crotonamide and 20 g (0.2 mol) triethylamine were dissolved in 100 mL of dimethylformamide, purged with nitrogen for three times, and heated to 130° C. in an airtight manner, and stirred continuously for 20 h.

待反应结束后,冷却,用硅藻土滤去不溶物,滤液真空除去溶剂,用热水提取残留物两次,弃去水相,残留物用乙醇重结晶,得到20.5克的3-(6-甲氧基萘基-2-)巴豆酰胺(核磁氢谱及碳谱参见图1和2),收率为85%。After the reaction was completed, it was cooled, the insolubles were filtered off with celite, the solvent was removed from the filtrate in vacuo, the residue was extracted twice with hot water, the aqueous phase was discarded, and the residue was recrystallized with ethanol to obtain 20.5 g of 3-(6). -Methoxynaphthyl-2-)crotonamide (see Figures 1 and 2 for hydrogen NMR and carbon spectra), the yield was 85%.

(2)消旋萘普生的合成(2) Synthesis of racemic naproxen

Figure BDA0003031138420000051
Figure BDA0003031138420000051

在100mL含有0.12mol次氯酸钠、0.24mol氢氧化钠的水溶液中,滴入150mL含有24克(0.1mol)3-(6-甲氧基萘基-2-)巴豆酰胺的二氧六环溶液,冰浴保持反应温度不超过10℃,薄层色谱监测原料反应完全后,滴入亚硫酸钠水溶液至淀粉碘化钾试纸不再变蓝。In 100 mL of an aqueous solution containing 0.12 mol of sodium hypochlorite and 0.24 mol of sodium hydroxide, drop 150 mL of a dioxane solution containing 24 g (0.1 mol) of 3-(6-methoxynaphthyl-2-) crotonamide, on ice. The reaction temperature of the bath is kept not more than 10°C. After the reaction of the raw materials is monitored by thin layer chromatography, the sodium sulfite aqueous solution is added dropwise until the starch potassium iodide test paper no longer turns blue.

采用磷酸(其他酸效果差)调节pH值至中性,加热回流3h,冷却至常温,加入亚氯酸钠水溶液,搅拌过夜至薄层色谱显示芳基丙醛反应完全。Use phosphoric acid (other acids have poor effect) to adjust the pH value to neutrality, heat under reflux for 3 hours, cool to room temperature, add aqueous sodium chlorite solution, and stir overnight until thin layer chromatography shows that the reaction of arylpropionaldehyde is complete.

采用磷酸(其他酸效果差)调节溶液至pH小于3,冰水浴冷却,过滤,滤饼水洗。滤液采用二氯甲烷萃取后真空除去溶剂,残渣与滤饼合并,乙醇重结晶,得到19.2克的消旋萘普生,收率为83%,核磁氢谱与碳谱见图3和图4。Use phosphoric acid (other acids have poor effect) to adjust the pH of the solution to less than 3, cool in an ice-water bath, filter, and wash the filter cake with water. The filtrate was extracted with dichloromethane, and the solvent was removed in vacuo. The residue was combined with the filter cake and recrystallized from ethanol to obtain 19.2 g of racemic naproxen with a yield of 83%.

尽管本发明的内容已经通过上述优选实施例作了详细介绍,但应当认识到上述的描述不应被认为是对本发明的限制。在本领域技术人员阅读了上述内容后,对于本发明的多种修改和替代都将是显而易见的。因此,本发明的保护范围应由所附的权利要求来限定。While the content of the present invention has been described in detail by way of the above preferred embodiments, it should be appreciated that the above description should not be construed as limiting the present invention. Various modifications and alternatives to the present invention will be apparent to those skilled in the art upon reading the foregoing. Accordingly, the scope of protection of the present invention should be defined by the appended claims.

Claims (10)

1. A novel process for synthesizing racemic naproxen based on Heck coupling is characterized in that the synthesis route of the process is as follows:
Figure DEST_PATH_IMAGE001
(1) performing Heck coupling reaction on 2-X substituted-6-methoxynaphthalene and crotonamide in an aprotic organic solvent under the action of a palladium catalyst and alkali to generate 3- (6-methoxynaphthyl-2-) -crotonamide;
(2) carrying out Hofmann degradation reaction on 3- (6-methoxynaphthyl-2-) -crotonamide in an alkaline solution of hypochlorite to generate 2- (6-methoxynaphthyl-2-) -propionaldehyde, directly adding chlorite without separation into the 2- (6-methoxynaphthyl-2-) -propionaldehyde, and oxidizing at room temperature to obtain racemic naproxen;
wherein in the structure of the 2-X substituted-6-methoxynaphthalene, X is selected from halogen or halogen-like, and the halogen-like is selected from halogen
Figure DEST_PATH_IMAGE002
Figure DEST_PATH_IMAGE003
Or
Figure DEST_PATH_IMAGE004
The aprotic organic solvent is selected from one or more of N, N-dimethylformamide, dimethyl sulfoxide, N-dimethylacetamide, acetonitrile, dioxane, toluene, benzene, xylene and tetrahydrofuran;
in the structure of the crotonamide, the configuration of a double bond is Z type or E type, or the crotonamide is a mixture of two configurations;
the palladium catalyst is PdLnYmL is selected from arylphosphine ligands, n is an integer between 0 and 4, and n is not 0; y is selected from halogen anions or carboxylate radicals, m is an integer between 0 and 4, and m is not 0;
the alkali in the Heck coupling reaction is selected from any one or more than two of triethylamine, diethylamine, potassium carbonate, sodium carbonate, potassium bicarbonate, sodium bicarbonate, potassium phosphate, sodium phosphate, potassium acetate and sodium acetate;
the alkali in the Hofmann degradation reaction is selected from potassium hydroxide and/or sodium hydroxide.
2. The novel Heck coupling-based process for synthesizing racemic naproxen according to claim 1, wherein the Heck coupling reaction is: 2-bromo-6-methoxynaphthalene and PdYmDissolving the ligand L, crotonamide and alkali in an aprotic organic solvent, purging with nitrogen, sealing, heating to 130 ℃, and reacting under stirring to obtain the 3- (6-methoxynaphthyl-2-) -crotonamide.
3. The novel Heck coupling-based process for synthesizing racemic naproxen according to claim 2, wherein the 2-bromo-6-methoxynaphthalene, PdYmThe molar ratio of the ligand L to the crotonamide to the base is 1: 0.005:0.01:1.5:2。
4. The novel Heck coupling based racemic naproxen synthesis process according to claim 2, wherein the base is triethylamine; the ligand L is tri (2-methylphenyl) -phosphine; the PdymIs PdCl2
5. The novel process for synthesizing racemic naproxen based on Heck coupling according to claim 2, characterized in that after the Heck coupling reaction is finished, insoluble substances are filtered, the filtrate is concentrated, the concentrate is extracted by hot water, the water phase is discarded, and the residue is recrystallized by hydrous ethanol, methanol or isopropanol to obtain 3- (6-methoxy-naphthyl-2-) crotonamide.
6. The novel Heck coupling-based racemic naproxen synthesis process according to claim 5, wherein after the Heck coupling reaction is finished, insoluble substances are filtered out by using diatomite.
7. The novel Heck coupling based racemic naproxen synthesis process according to claim 1, wherein the hofmann degradation reaction is: dripping an aprotic organic solvent containing 3- (6-methoxynaphthyl-2-) crotonamide into a polar solvent containing hypochlorite and hydroxide, keeping the reaction temperature not higher than 10 ℃, removing the hypochlorite in a reaction liquid after the reaction is finished, then adjusting the pH value to be neutral, and heating and refluxing to obtain 2- (6-methoxynaphthyl-2-) -propionaldehyde;
wherein the polar solvent is selected from water or aqueous methanol.
8. The novel Heck coupling based process for the synthesis of racemic naproxen according to claim 7, characterized in that the molar ratio of hypochlorite, hydroxide and 3- (6-methoxynaphthyl-2-) crotonamide is 1.2: 2.4: 1; the hypochlorite is sodium hypochlorite or potassium hypochlorite, and the hydroxide is sodium hydroxide or potassium hydroxide.
9. The novel Heck coupling based process for the synthesis of racemic naproxen according to claim 7, wherein said hypochlorite and chlorite are removed by using an aqueous sulfite solution.
10. The novel Heck-based coupling synthesis process of racemic naproxen according to claim 1, wherein after the 2- (6-methoxynaphthalene-2-) -propionaldehyde reacts with chlorite, the solution is adjusted to have a pH value of less than 3, the solution is cooled, filtered, the filter cake is washed with water, the filtrate is extracted by dichloromethane or dichloroethane and then concentrated, the concentrate is combined with the filter cake, and the filtrate is recrystallized by using aqueous ethanol, methanol or isopropanol to obtain racemic naproxen.
CN202110433122.XA 2021-04-21 2021-04-21 A new process for the synthesis of racemic naproxen based on Heck coupling Active CN113200841B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110433122.XA CN113200841B (en) 2021-04-21 2021-04-21 A new process for the synthesis of racemic naproxen based on Heck coupling

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110433122.XA CN113200841B (en) 2021-04-21 2021-04-21 A new process for the synthesis of racemic naproxen based on Heck coupling

Publications (2)

Publication Number Publication Date
CN113200841A CN113200841A (en) 2021-08-03
CN113200841B true CN113200841B (en) 2022-05-20

Family

ID=77027686

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110433122.XA Active CN113200841B (en) 2021-04-21 2021-04-21 A new process for the synthesis of racemic naproxen based on Heck coupling

Country Status (1)

Country Link
CN (1) CN113200841B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113845417B (en) * 2021-09-28 2023-11-07 浙江车头制药股份有限公司 Method for synthesizing (+/-) -naproxen by using continuous flow micro-channel reactor oxidation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1110677A (en) * 1994-12-15 1995-10-25 潘则林 Synthetic technology of phenylacetic acid
CA2550372C (en) * 2003-12-22 2009-09-29 Merck & Co., Inc. Alpha-hydroxy amides as bradykinin antagonists or inverse agonists
CN101486643B (en) * 2009-02-24 2012-08-15 湖南大学 Trans naproxen ester, optical isomer thereof, as well as preparation and use thereof
CN103087105B (en) * 2013-01-18 2015-08-05 中国科学院上海有机化学研究所 Chiral phosphine ligand and comprise the metal catalyst of this part and their application

Also Published As

Publication number Publication date
CN113200841A (en) 2021-08-03

Similar Documents

Publication Publication Date Title
JP7087103B2 (en) Roxadustat synthesis method and its intermediate compounds
CN107857743B (en) Method for preparing roxatidine acetate hydrochloride and intermediate
CN113200841B (en) A new process for the synthesis of racemic naproxen based on Heck coupling
JP2022508494A (en) Method for Producing Morpholine Quinazoline Compound and its Intermediate
CN102070586B (en) A kind of processing method of synthesizing 4-position hybrid atom MCM-41 cyclohexenyl halides
CN115304581B (en) Preparation method of intermediate pyrazole acid and application of intermediate pyrazole acid in preparation of bisamide pesticide
JP2008162979A (en) Method for synthesizing bis (terpyridine) compounds
JP5092140B2 (en) Method for synthesizing asymmetric bis (terpyridine) compounds
JP5013365B2 (en) Method for synthesizing spacer-introduced bis (terpyridine) compounds
CN109776617B (en) A kind of acetone coordination binuclear palladium compound and preparation method and application thereof
CN115677636B (en) Preparation method of 2, 3',4' -biphenyl tetracarboxylic dianhydride
EP2626362A1 (en) Synthesis of water-soluble phosphine oxides by Pd/C-catalyzed P-C coupling in water
CN116078435A (en) Use of diamide acid ligands for copper-catalyzed (hetero) aryl halide reactions
CN112675920B (en) A class of monochiral center catalysts and methods for preparing and catalytically synthesizing chiral alcohol compounds and chiral α-allyl alcohols
CN105037422B (en) A kind of preparation method of indole phosphonate derivative
CN105601472B (en) The preparation method of new 5 [4 (1 carboxyl naphthyl)] M-phthalic acid
CN105111228A (en) Chiral phosphoric acid with 5,5'-bitetralone skeleton and preparation method thereof
CN114790133A (en) Method for synthesizing 2-chloro-4-fluorobenzoic acid by taking 2-chloro-4-aminobenzonitrile as raw material
CN108623496B (en) Preparation method of 3-ethyl-4-fluorobenzonitrile
WO2020253533A1 (en) Synthesis method for 1-methyl-1h-indazole-6-carboxylic acid
CN102367225B (en) A kind of preparation method of naproxen
CN110746278B (en) Nonmetal-catalyzed method for preparing 1, 3-diketone compound based on alkynone
CN104418805B (en) Dabigatran etexilate intermediate as well as preparation method and application thereof
CN102731389B (en) Synthesis method of (R)/(S)-6,6'-benzyloxyl-5,5'-biquinoline
CN114832862A (en) Catalytic composition for coupling reaction and application thereof in preparation of isoquinoline-1, 3-diketone compounds

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP03 Change of name, title or address

Address after: 314000 No. 899, guangqiong Road, Nanhu District, Jiaxing City, Zhejiang Province

Patentee after: Jiaxing University

Country or region after: China

Address before: No. 899 Guangqiong Road, Nanhu District, Jiaxing City, Zhejiang Province

Patentee before: JIAXING University

Country or region before: China

CP03 Change of name, title or address